GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NetScientific PLC (STU:NTK1) » Definitions » Gross Margin %

NetScientific (STU:NTK1) Gross Margin % : 93.20% (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is NetScientific Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. NetScientific's Gross Profit for the six months ended in Jun. 2023 was €0.84 Mil. NetScientific's Revenue for the six months ended in Jun. 2023 was €0.90 Mil. Therefore, NetScientific's Gross Margin % for the quarter that ended in Jun. 2023 was 93.20%.


The historical rank and industry rank for NetScientific's Gross Margin % or its related term are showing as below:

STU:NTK1' s Gross Margin % Range Over the Past 10 Years
Min: 50.77   Med: 74.66   Max: 89.34
Current: 82.29


During the past 13 years, the highest Gross Margin % of NetScientific was 89.34%. The lowest was 50.77%. And the median was 74.66%.

STU:NTK1's Gross Margin % is ranked better than
76.19% of 735 companies
in the Biotechnology industry
Industry Median: 59.4 vs STU:NTK1: 82.29

NetScientific had a gross margin of 93.20% for the quarter that ended in Jun. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for NetScientific was 8.20% per year.


NetScientific Gross Margin % Historical Data

The historical data trend for NetScientific's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetScientific Gross Margin % Chart

NetScientific Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.13 84.08 88.28 89.33 77.90

NetScientific Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.35 88.11 92.32 68.65 93.20

Competitive Comparison of NetScientific's Gross Margin %

For the Biotechnology subindustry, NetScientific's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NetScientific's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NetScientific's Gross Margin % distribution charts can be found below:

* The bar in red indicates where NetScientific's Gross Margin % falls into.



NetScientific Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

NetScientific's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=0.9 / 1.154
=(Revenue - Cost of Goods Sold) / Revenue
=(1.154 - 0.255) / 1.154
=77.90 %

NetScientific's Gross Margin for the quarter that ended in Jun. 2023 is calculated as


Gross Margin % (Q: Jun. 2023 )=Gross Profit (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=0.8 / 0.897
=(Revenue - Cost of Goods Sold) / Revenue
=(0.897 - 0.061) / 0.897
=93.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


NetScientific  (STU:NTK1) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

NetScientific had a gross margin of 93.20% for the quarter that ended in Jun. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


NetScientific Gross Margin % Related Terms

Thank you for viewing the detailed overview of NetScientific's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


NetScientific (STU:NTK1) Business Description

Traded in Other Exchanges
Address
20 Saint Andrew Street, Holborn Circus, London, GBR, EC4A 3AG
NetScientific PLC is a transatlantic healthcare technology company. The group is focused on sourcing, funding and commercializing technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients, Glucosense a provider of a non-invasive glucose monitoring wearable device, Vortex Biosciences which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing, and Glycotest which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis.

NetScientific (STU:NTK1) Headlines

No Headlines